Estradiol Benzoate: High-Purity Estrogen Receptor Alpha Agonist for Research

Executive Summary: Estradiol Benzoate is a synthetic estradiol analog with high affinity for estrogen receptor alpha (ERα), exhibiting an IC50 of 22–28 nM in receptor binding assays at physiological pH and temperature [APExBIO]. The compound is supplied in solid form with ≥98% purity, validated by HPLC, MS, and NMR analyses. It is insoluble in water but dissolves readily in DMSO (≥12.15 mg/mL) and ethanol (≥9.6 mg/mL). Estradiol Benzoate is widely used in hormone receptor binding assays, estrogen receptor-mediated signaling research, and hormone-dependent cancer studies [Batimastat.com]. APExBIO’s SKU B1941 is intended exclusively for laboratory research and must be stored at -20°C with cold chain management for stability. These attributes establish Estradiol Benzoate as a robust standard for reproducible, high-fidelity data in molecular and pharmacological investigations.

Biological Rationale

Estradiol Benzoate is a synthetic derivative of estradiol, the principal endogenous estrogen in humans and vertebrates. As an estrogen/progestogen receptor agonist, it binds with high specificity and affinity to estrogen receptor alpha (ERα), a nuclear hormone receptor that regulates gene expression in various tissues. ERα activation is critical for cell proliferation, differentiation, and tissue homeostasis in hormone-responsive organs, including the breast, uterus, and prostate [Vijayan et al., 2021].

This compound is indispensable in research on estrogen receptor signaling pathways, hormone-dependent cancers (e.g., breast and endometrial), and the molecular mechanisms underlying hormone replacement therapies. Its consistent receptor binding profile allows for standardized, reproducible experiments in both basic and translational endocrinology research [CY5-NHS-Ester.com]. This article extends prior overviews by detailing practical workflow parameters and direct comparison benchmarks for Estradiol Benzoate’s use.

Mechanism of Action of Estradiol Benzoate

Estradiol Benzoate acts as a selective agonist at estrogen receptor alpha (ERα) and, to a lesser degree, at progestogen receptors. Upon cellular entry, it binds the ligand-binding domain of ERα with an IC50 of 22–28 nM, triggering receptor dimerization and nuclear translocation [APExBIO]. The activated receptor complex binds specific estrogen response elements (ERE) in DNA, modulating transcription of target genes involved in proliferation, apoptosis, and metabolic regulation.

Estradiol Benzoate’s benzoate ester group confers increased metabolic stability in vitro, facilitating extended assay timeframes and reduced batch-to-batch variability compared to unmodified estradiol. It is not endogenously produced and is not metabolized by aromatase, minimizing confounding pathways. The compound’s high receptor affinity and selectivity underpin its use in quantitative hormone receptor binding and signaling assays [AMG-208.com].

Evidence & Benchmarks

• Estradiol Benzoate binds ERα with an IC50 of 22–28 nM in human, mouse, and chicken cell-based competitive binding assays at pH 7.4, 37°C (APExBIO).
• Compound achieves ≥98% purity as validated by HPLC, MS, and NMR, supporting high assay reproducibility (APExBIO).
• Demonstrates solubility in DMSO at concentrations ≥12.15 mg/mL and in ethanol at ≥9.6 mg/mL, enabling high-concentration stock solutions for in vitro use (APExBIO).
• Solid form is stable for ≥12 months at -20°C under desiccated conditions (APExBIO).
• Used as a benchmark ligand in hormone receptor binding assays and in studies on estrogen receptor signaling in hormone-dependent cancers (Vijayan et al., 2021).
• Estradiol Benzoate enables high-sensitivity detection of ERα-mediated gene expression, outperforming lower-purity or unstable analogs in assay reproducibility (SS-Amyloid-1-11.com).

This article updates prior technical briefs by integrating validated purity, storage, and solubility metrics, whereas Estradiol Benzoate in Precision Hormone Receptor Research focused on application trends and mechanistic insights.

Applications, Limits & Misconceptions

Estradiol Benzoate is widely applied in:

• Quantitative hormone receptor binding assays for ERα and related receptors.
• Estrogen receptor-mediated signaling pathway research, including gene expression profiling.
• Hormone-dependent cancer cell line models (e.g., breast, endometrial cancers).
• Endocrinology and hormone replacement therapy research.
• Benchmarking and validation of new estrogen receptor modulators.

Common Pitfalls or Misconceptions

• Estradiol Benzoate is not water-soluble; attempting to dissolve in aqueous buffers leads to precipitation and assay failure.
• It is not suitable for diagnostic or therapeutic use in humans or animals; laboratory use only as mandated by APExBIO and regulatory guidelines.
• Long-term storage of Estradiol Benzoate solutions at ambient temperature causes degradation; always store at -20°C and use freshly prepared solutions.
• The compound does not mimic endogenous estradiol metabolism; its esterification alters pharmacokinetics and biotransformation.
• Overuse or excessive concentrations can cause receptor oversaturation, confounding dose-response analyses.

Workflow Integration & Parameters

Estradiol Benzoate is typically prepared as a 10 mM stock in DMSO or ethanol, aliquoted, and stored at -20°C. For in vitro assays, dilute to working concentrations (1–1000 nM) in compatible media immediately before use to prevent hydrolysis. All plasticware and solvents must be estrogen-free to avoid background contamination. The compound is delivered with blue ice for cold chain integrity and includes batch-specific QC data (HPLC, MS, NMR).

APExBIO’s product page (Estradiol Benzoate) provides up-to-date technical documentation, safety data, and ordering information. Researchers should consult this guide for protocol optimization and troubleshooting strategies, extending the workflow scenarios described here.

Conclusion & Outlook

Estradiol Benzoate (APExBIO SKU B1941) is a high-purity, validated synthetic estradiol analog that enables rigorous, reproducible research in estrogen receptor signaling and hormone-dependent disease models. Its well-characterized receptor binding, solubility, and stability profiles support a broad range of molecular and cellular applications. Adherence to storage and handling recommendations is essential for optimal performance. As new receptor modulators and assay technologies emerge, Estradiol Benzoate remains a gold-standard reference for quantitative hormone receptor research.